Options Brief: AMAG Pharmaceuticals (AMAG)

Shares of AMAG Pharmaceuticals AMAG are higher on the session by 1.44%, trading at $18.29. Overall call volume is now running at 6.67x the daily average, with 63% of all calls traded being purchases on the offer. 1,747 contracts have traded on the session so far. AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which utilizes the technology for the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and imaging agents to aid in the diagnosis of cancer and cardiovascular disease.